http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103251654-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6f4dd413a1798462b448fe1cad85342
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-618
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
filingDate 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a39fea8c7d802865b1fbda3e7d0789a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b33d1a57ce2a50ff44f02eda19f78527
publicationDate 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103251654-B
titleOfInvention Pearl powder vitamin C and E capsule and preparation method thereof
abstract The invention relates to a pearl powder vitamin C and E capsule. Most health care products sold on the market only can supplement a single element, and the absorption effect of an organism on effective ingredients of the products is poor even the effective ingredients of the products are taken into the organism. The content of the pearl powder vitamin C and E capsule is prepared from the following components in parts by weight: 135-165 parts of pearl powder, 18-22 parts of natural vitamin E, 176.4-215.6 parts of pregelatinized starch, 3.6-4.4 parts of magnesium stearate and 117-143 parts of coated vitamin C. The invention also relates to a preparation method of the pearl powder vitamin C and E capsule. The pearl powder vitamin C and E capsule can jointly supplement microelements necessary for immune organs, and reasonable compatibility is adopted, so that acceleration of each component to other components is enhanced, the pearl powder vitamin C and E capsule is widely applicable to enhancement of autoimmunity of population in each age group and is especially applicable to crowd with low immunity.
priorityDate 2013-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5MBK3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2UCT7
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1125397
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8VUZ6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9RF12
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33378
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C1C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP98160
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551942
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1125397
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C1C2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5BEB9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86472
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832091
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C216
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP59026
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA2QW65
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6CZT2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ0TV31
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02158

Total number of triples: 45.